Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Learn the best ways students can earn money fast with quick income solutions. Start boosting your finances today.
27,906 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A rising trend among affluent couples sees them drawing down the 401K early while delaying Social Security to 70, loc...
Brazil’s B3 has integrated a crypto ETF-linked instrument into its core clearing and settlement system, marking a mil...
Investors bias portfolios by political leanings, potentially hurting gains. Experts say open dialogue across camps ca...
Arm Holdings has ridden a scorching AI-fueled rally in 2026, but today’s roughly 10% slide raises questions about mom...
As valuations run high, retirement plans face tighter assumptions. Experts urge conservative return targets and diver...
Bitcoin now faces a fresh macro signal after Quantitative Tightening ended in late 2025. Analysts highlight bounce po...
CFOs and boards are confronting a pivotal moment: how well they govern AI agents to protect value and manage risk. Th...
Suze Orman declares delaying withdrawals until Required Minimum Distributions begin as a costly mistake for retirees,...
Bezos-backed Prometheus closed a $12 billion private round, signaling a major push into AI-enabled industrial design ...
Grayscale argues that saylor’s strategy $1.5bb cashflow is being squeezed by a growing load of preferred-stock obliga...
A couple with about $2M saved, no debt, and a paid-off home faces a looming retirement tax bill, according to Suze Or...